Abstract

Differences in rapid-acting opioid dosage forms for cancer-related BTP: a review of comparative effectiveness studies

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
A comparison of intranasal fentanyl spray with oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: an open-label, randomised, crossover trial
S Mercadante ... A Davies
Current Medical Research and Opinion | VOL. 25
S Mercadante, et. al.S Mercadante ... A Davies
30 Sep 2009
Intranasal fentanyl spray for breakthrough cancer pain: An innovative approach to the unmet needs
Hans G Kress
European Journal of Pain Supplements | VOL. 4
Hans G KressHans G Kress
21 Aug 2010
Faster absorption and higher systemic bioavailability of intranasal fentanyl spray compared to oral transmucosal fentanyl citrate in healthy subjects
Lars Popper ... Ruediger Nave
Drug Delivery | VOL. 20
Lars Popper, et. al.Lars Popper ... Ruediger Nave
08 May 2013
Opioids for the management of breakthrough (episodic) pain in cancer patients
Maria Dc Ribeiro ... Giovambattista Zeppetella
-
Maria Dc Ribeiro, et. al.Maria Dc Ribeiro ... Giovambattista Zeppetella
25 Jan 2006
View more papers

More From: The Journal of Pain

Paper Title
Journal
Date
Author
Table of Contents
-
The Journal of Pain | VOL. 25
--
01 Jun 2024
Masthead
-
The Journal of Pain | VOL. 25
--
01 Jun 2024
Editorial Board
-
The Journal of Pain | VOL. 25
--
01 Jun 2024
Treatment effect modifiers for return-to-work in patients with musculoskeletal disorders.
Martjie Venter ... Aidan G Cashin
The journal of pain | VOL. -
Martjie Venter, et. al.Martjie Venter ... Aidan G Cashin
04 May 2024
View more papers